眼科 ›› 2025, Vol. 34 ›› Issue (6): 431-439.doi: 10.1328 1/i.cnki.issn.1004-4469.2025.06.004

• 论著 • 上一篇    下一篇

携带 FBNI 基因致病变异患者表型多样性分析

闫玮玉 田露 许可 谢玥 李妮蒽 夏伟乔 金子兵 李杨   

  1. 首都医科大学附属北京同仁医院 北京同仁眼科中心 北京市眼科研究所 眼科学与视觉科学北京市重点实验室,北京 100730
  • 收稿日期:2025-07-07 出版日期:2025-11-25 发布日期:2025-11-25
  • 通讯作者: 李杨,Email:yanglibio@aliyun.com
  • 基金资助:
    国家重点研发计划(2022YFC2703600)

Ocular phenotype diversity observed in a Chinese cohort of patients with FBN1 gene variants

Yan Weiyu, Tian Lu, Xu Ke, Xie Yue, Li Nien, Xia Weiqiao, Jin Zibing, Li Yang   

  1. Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University; Beijing Key Laboratory of Ophthalmology & Visual Sciences, Beijing 100730, China
  • Received:2025-07-07 Online:2025-11-25 Published:2025-11-25
  • Contact: Li Yang, Email: yanglibio@aliyun.com
  • Supported by:
    National Key R&D Program of China (2022YFC2703600)

摘要: 目的  描述一组携带FBN1基因致病变异患者的基因型和临床特征,并探讨眼部表型与基因型的关系。设计  回顾性病例系列。研究对象 携带FBN1致病变异的24个无血缘关系家系中的36例患者。 方法 对患者进行详细的眼科检查,采集先证者及直系亲属外周静脉血,提取DNA,通过一代测序、目标区域捕获确定致病基因变异,多种生物信息学分析软件预测变异致病性,并进行共分离验证。探讨基因型与表型的关系。主要指标  致病基因变异、眼部临床表现、全身表现。结果  共检出23种致病变异,其中7种为首次报道。变异类型以错义变异为主(占91.3%),1个框内缺失及1个累及47-54外显子的大片段缺失。患者临床表现多样,从典型的Marfan综合征到单纯性晶状体脱位及Weill Marchesani综合征。所有携带半胱氨酸替换变异的患者均有晶状体脱位及高度近视,其中30%的患者出现视网膜脱离。而携带半胱氨酸产生变异患者散光程度更高。一例携带复合杂合变异患者表现出严重的眼部及心血管表型。结论 本研究扩大了FBN1基因的致病变异谱。携带半胱氨酸替换变异的患者发生视网膜脱离的几率高,将为遗传咨询及视网膜脱离风险的预防性治疗提供一定的依据。

关键词: Marfan综合征, FBN1, 晶状体脱位, 表型, 基因变异

Abstract:  Objective  To describe the genetic and clinical characteristics of a cohort of Chinese patients with FBN1 variants and to explore genotype-phenotype correlations in ocular manifestations. Design Retrospective case series. Participants 36 patients from 24 unrelated families who carried variants in FBN1. Methods Detailed ophthalmic/systemic evaluations were performed on the patients. Peripheral venous blood was collected from family members. Sanger sequencing was employed for validation and family co-segregation analysis to identify pathogenic variant sites. Main Outcome Measures Pathogenic gene variants, ocular clinical manifestations, and systemic manifestations. Results 23 variants in FBN1 were identified; seven variants were novel. The variants included 21 (91.3%) missense variants, one in-frame deletion, and one large novel deletion encompassing exon 47-54. The patients showed clinical diversity, ranging from typical Marfan syndrome to isolated ectopia lentis (EL) and Weill Marchesani syndrome. All patients with cysteine-erasing missense variants suffered from EL and high myopia, and approximately 30% occurred retinal detachment(RD). Conversely, patients with cysteine-forming variants exhibited a higher prevalence and severity of astigmatism. A patient with compound-heterozygous missense variants exhibited severe ocular and cardiovascular manifestations. Conclusions Our results expanded the pathogenic variant spectrum of FBN1. We observed that patients with cysteine-erasing missense variants were at a high risk of RD. These findings will provide some basis for genetic counselling and preventive treatment of RD risk.

Key words: Marfan syndrome, FBN1 , gene, Ectopia lentis, Phenotype, Gene variation